Both near-term and longer-term technicals are bearish for Cameco stock as the chart, moving averages, and indicators show a worrying outlook. Most recent earnings results were mixed as revenue ...

Cameco Corporation (NYSE:CCJ) is a leading provider of nuclear fuel solutions and a major supplier of uraniuma critical element in nuclear fission power generation. As tech giants increasingly ...

The most recent trading session ended with Cameco (CCJ) standing at $49.44, reflecting a -1.71% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.51% loss on the day.

Cameco (NYSE:CCJ) said Monday that uranium production was resumed at the Inkai joint venture project in Kazakhstan by its partner Kazatomprom, the country's national uranium producer. Inkai had ...

Cameco (CCJ) was informed by our partner, National Atomic Company Kazatomprom JSC, and Joint Venture Inkai, that the Inkai operation has resumed production. Cameco and Kazatomprom are now working ...

Cameco’s (TSX: CCO, NYSE: CCJ) joint venture project (JV Inkai LLP) in Kazakhstan has resumed uranium production, Kazakhstan’s national uranium producer Kazatomprom (LSE: KAP) announced on ...

Several other research firms have also commented on CCO. Raymond James increased their target price on shares of Cameco from C$81.00 to C$88.00 in a report on Friday, November 22nd. Scotiabank ...

Cameco (CCJ) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Deep-pocketed investors have adopted a bearish approach towards Cameco (NYSE:CCJ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled ...

On top of all this, Cameco did its industry no favors this morning by announcing that its Inkai joint venture with Kazakhstan's national atomic energy company Kazatomprom is resuming uranium ...